BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19797519)

  • 1. How I treat acute promyelocytic leukemia.
    Tallman MS; Altman JK
    Blood; 2009 Dec; 114(25):5126-35. PubMed ID: 19797519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary treatment of APL.
    Cull EH; Altman JK
    Curr Hematol Malig Rep; 2014 Jun; 9(2):193-201. PubMed ID: 24643310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating low- and intermediate-risk acute promyelocytic leukemia with and without chemotherapy: A comparison in a tertiary care center.
    Saxena M; Madabhavi IV; Patel A; Panchal H; Anand A
    J Cancer Res Ther; 2023; 19(5):1371-1378. PubMed ID: 37787311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of end of induction bone marrow biopsy and survival outcomes in acute promyelocytic leukemia treated with fixed-dose induction regimen.
    Dunn-Valadez S; Bathini S; Purdy KE; Bachiashvili K; Bhatia R; Jamy O; Rangaraju S; Mehta A; Godby K; Goyal G; Worth S; Oliver JD; Mikhail FM; Choi JK; Morlote D; Reddy VB; Vachhani P
    Leuk Lymphoma; 2023 Oct; 64(10):1673-1680. PubMed ID: 37493540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.
    Arteaga MF; Mikesch JH; Fung TK; So CW
    Br J Cancer; 2015 Feb; 112(3):413-8. PubMed ID: 25247321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid.
    Singh C; Saini M; Jain A; Lad D; Prakash G; Khadwal A; Naseem S; Malhotra P
    Blood Cancer J; 2024 Jan; 14(1):14. PubMed ID: 38238308
    [No Abstract]   [Full Text] [Related]  

  • 7. How to avoid early mortality in acute promyelocytic leukemia.
    Odetola O; Tallman MS
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):248-253. PubMed ID: 38066899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Promyelocytic Leukemia.
    Winkler C
    N Engl J Med; 2024 May; 390(17):e42. PubMed ID: 38683728
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of hospital volume and physician volume on early mortality in acute promyelocytic leukemia patients.
    Wu CY; Yeh CM; Tsai CK; Liu CJ
    Ann Hematol; 2024 May; 103(5):1577-1586. PubMed ID: 38532122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
    Costa A; Carmosino I; Scalzulli E; Minotti C; De Propris MS; Masucci C; Passucci M; Bisegna ML; Ielo C; Pepe S; Diverio D; Martelli M; Breccia M
    Eur J Haematol; 2024 Apr; 112(4):654-657. PubMed ID: 38093665
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
    N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.
    Sanz MA; Montesinos P
    Blood; 2014 May; 123(18):2777-82. PubMed ID: 24627526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia: what is the new standard of care?
    Watts JM; Tallman MS
    Blood Rev; 2014 Sep; 28(5):205-12. PubMed ID: 25107311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
    Iland HJ; Bradstock K; Supple SG; Catalano A; Collins M; Hertzberg M; Browett P; Grigg A; Firkin F; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
    Blood; 2012 Aug; 120(8):1570-80; quiz 1752. PubMed ID: 22715121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
    Sanz MA; Fenaux P; Tallman MS; Estey EH; Löwenberg B; Naoe T; Lengfelder E; Döhner H; Burnett AK; Chen SJ; Mathews V; Iland H; Rego E; Kantarjian H; Adès L; Avvisati G; Montesinos P; Platzbecker U; Ravandi F; Russell NH; Lo-Coco F
    Blood; 2019 Apr; 133(15):1630-1643. PubMed ID: 30803991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Acute Promyelocytic Leukemia in Adults.
    Osman AEG; Anderson J; Churpek JE; Christ TN; Curran E; Godley LA; Liu H; Thirman MJ; Odenike T; Stock W; Larson RA
    J Oncol Pract; 2018 Nov; 14(11):649-657. PubMed ID: 30423270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Relapsed/Refractory Acute Myeloid Leukemia.
    Bose P; Vachhani P; Cortes JE
    Curr Treat Options Oncol; 2017 Mar; 18(3):17. PubMed ID: 28286924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Myeloid Leukemia.
    Döhner H; Weisdorf DJ; Bloomfield CD
    N Engl J Med; 2015 Sep; 373(12):1136-52. PubMed ID: 26376137
    [No Abstract]   [Full Text] [Related]  

  • 19. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of acute promyelocytic leukemia treated with all-
    Abaza Y; Kantarjian H; Garcia-Manero G; Estey E; Borthakur G; Jabbour E; Faderl S; O'Brien S; Wierda W; Pierce S; Brandt M; McCue D; Luthra R; Patel K; Kornblau S; Kadia T; Daver N; DiNardo C; Jain N; Verstovsek S; Ferrajoli A; Andreeff M; Konopleva M; Estrov Z; Foudray M; McCue D; Cortes J; Ravandi F
    Blood; 2017 Mar; 129(10):1275-1283. PubMed ID: 28003274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.